DJIA 17,949.59 -85.34 -0.47%
NASDAQ 5,014.10 19.50 0.39%
S&P 500 2,097.29 -3.11 -0.15%
market minute promo

ImmunoGen (NASDAQ: IMGN)

9.95 -0.14 (-1.39%)

REAL-TIME: Last trade at

Extended Hours: $11.13 $1.18 (11.86%)
Quote as of (NASDAQ)

company name or ticker

Recent Quotes

IMGN $9.95 -1.39%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $10.02
Previous Close $10.09
Daily Range $9.91 - $10.29
52-Week Range $5.34 - $14.80
Market Cap $856.8M
P/E Ratio -12.01
Dividend (Yield) $0.00 (0.0%)
Volume 895,423
Average Daily Volume 1,770,286
Current FY EPS -$0.69




Drug Makers

ImmunoGen (IMGN) Description

ImmunoGen develops cancer therapeutics through its tumor-activated, prodrug technology, which targets antibodies with cancer-killing drugs. Website:

News & Commentary Rss Feed

Best Pure Play Investment in Cancer Drugs

Global cancer drug sales could soon soar past $100 billion, making this pure play in cancer drugs a stock you should seriously consider owning.

Will Alexion's (ALXN) Soliris Drive Q1 Earnings Beat? - Analyst Blog

Is AbbVie (ABBV) Set to Top 1Q Earnings on Humira & HCV? - Analyst Blog

Biotech Investors: May 29th Could Be A Big Day

Will Amgen (AMGN) Keep Earnings Streak Alive in 1Q? - Analyst Blog

5 Biotech Earnings Under The Microscope This Week

Will Pharmaceutical Sales Drive J&J (JNJ) Earnings Again? - Analyst Blog

'Mad Money' Lightning Round: Buy, Buy, Buy Starbucks, AT&T

1 Small-Cap Biotech Stock to Buy and Hold For the Next 10 Years

Small cap biotech stocks have a lot of inherent risk, but if you can snag a winner your returns could double many times over. Here's one small-cap biotech stock you can consider buying and holding for the next 10 years.

5 Promising Biotech Stocks Under $10

Don't let their share price fool you. These five biotech stocks have the potential to double your money many times over if their product pipelines meet expectations.

See More IMGN News...

IMGN's Top Competitors

IMGN $9.95 (-1.39%)
Current stock: IMGN
AMGN $168.46 (1.50%)
Current stock: AMGN
GILD $105.20 (4.52%)
Current stock: GILD
BIIB $422.11 (-0.19%)
Current stock: BIIB